BSGM | BioSig Technologies, Inc.

Index- P/E- EPS (ttm)-0.55 Insider Own7.80% Shs Outstand61.43M Perf Week-21.29%
Market Cap93.16M Forward P/E- EPS next Y-0.35 Insider Trans0.00% Shs Float42.67M Perf Month-9.29%
Income-26.60M PEG- EPS next Q-0.10 Inst Own9.50% Short Float / Ratio4.34% / 5.77 Perf Quarter9.91%
Sales0.30M P/S310.53 EPS this Y32.90% Inst Trans0.55% Short Interest1.85M Perf Half Y192.85%
Book/sh0.03 P/B40.67 EPS next Y14.60% ROA-445.60% Target Price4.50 Perf Year32.67%
Cash/sh0.02 P/C62.11 EPS next 5Y- ROE-971.60% 52W Range0.25 - 1.65 Perf YTD190.48%
Dividend- P/FCF- EPS past 5Y12.60% ROI- 52W High-26.06% Beta1.41
Dividend %- Quick Ratio0.60 Sales past 5Y- Gross Margin79.90% 52W Low385.28% ATR0.14
Employees47 Current Ratio0.80 Sales Q/Q-37.50% Oper. Margin- RSI (14)39.72 Volatility14.78% 10.09%
OptionableYes Debt/Eq0.00 EPS Q/Q46.00% Profit Margin- Rel Volume0.98 Prev Close1.19
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume320.47K Price1.22
Recom2.00 SMA20-13.06% SMA50-4.82% SMA20037.84% Volume313,166 Change2.52%
Date Action Analyst Rating Change Price Target Change
Mar-30-20Initiated ROTH Capital Buy $9
May-25-23 09:00AM
May-19-23 07:30AM
May-03-23 09:00AM
Mar-27-23 08:38AM
Mar-24-23 08:30AM
07:30AM Loading…
Mar-13-23 07:30AM
Feb-22-23 07:30AM
Feb-17-23 07:30AM
Feb-07-23 08:00AM
Jan-19-23 08:30AM
Jan-10-23 08:30AM
Dec-14-22 04:30PM
Dec-06-22 08:30AM
11:03AM Loading…
Oct-24-22 11:03AM
Oct-12-22 10:00AM
Oct-07-22 09:35AM
Sep-22-22 09:00AM
Sep-16-22 09:30AM
Sep-09-22 07:15AM
Sep-08-22 12:33PM
Aug-30-22 09:37AM
Aug-24-22 09:17AM
Aug-17-22 09:15AM
Aug-16-22 09:47AM
Jul-21-22 10:00AM
Jul-07-22 08:30AM
Jun-29-22 05:45PM
Jun-24-22 09:30AM
04:26PM Loading…
Jun-23-22 04:26PM
Jun-22-22 08:00AM
May-31-22 09:25AM
May-26-22 09:08AM
May-25-22 09:47AM
May-12-22 05:55PM
May-11-22 08:30AM
May-05-22 06:55PM
May-04-22 07:55AM
Apr-19-22 09:10AM
Apr-07-22 08:30AM
Mar-29-22 10:06AM
Mar-23-22 08:00AM
Mar-22-22 08:00AM
Mar-16-22 09:00AM
Feb-08-22 01:38PM
Jan-26-22 01:00PM
Jan-07-22 10:20AM
Jan-06-22 08:30AM
Dec-21-21 09:00AM
Dec-16-21 09:15AM
Dec-13-21 08:30AM
Dec-06-21 10:00AM
Dec-01-21 09:25AM
Nov-17-21 09:45AM
Nov-16-21 09:52AM
Nov-11-21 02:45PM
Nov-10-21 09:20AM
Nov-08-21 11:30AM
Nov-04-21 11:00AM
Nov-01-21 12:30PM
Oct-13-21 09:01AM
Oct-12-21 09:15AM
Oct-07-21 12:41PM
Oct-04-21 08:30AM
Sep-28-21 09:15AM
Sep-23-21 09:47AM
Sep-21-21 10:30AM
Sep-17-21 07:40AM
Sep-13-21 08:00AM
Sep-02-21 09:41AM
Aug-31-21 10:00AM
Aug-19-21 11:00AM
Jul-20-21 02:00PM
Jul-13-21 02:30PM
Jul-12-21 10:30AM
Jul-07-21 04:10PM
Jul-06-21 09:44AM
Jul-02-21 09:37AM
Jul-01-21 04:05PM
Jun-30-21 10:03AM
Jun-28-21 09:45AM
Jun-22-21 10:06AM
Jun-15-21 02:14PM
Jun-07-21 08:30AM
May-28-21 10:30AM
May-24-21 09:44AM
May-21-21 09:15AM
May-04-21 06:28PM
May-03-21 12:00PM
Apr-27-21 09:30AM
Apr-15-21 11:45AM
Apr-14-21 09:29AM
BioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias. The company offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for catheter ablation procedures for arrhythmias. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sieckhaus JohnChief Operating OfficerSep 12Buy0.915,0004,55070,000Sep 12 02:42 PM
LONDONER KENNETH LChief Executive OfficerSep 09Buy0.8229,70024,2991,896,820Sep 12 10:28 AM
LONDONER KENNETH LChief Executive OfficerSep 08Buy0.8422,76619,0731,867,120Sep 12 10:28 AM
LONDONER KENNETH LChief Executive OfficerSep 07Buy0.867,2506,2071,844,354Sep 08 09:00 AM
LONDONER KENNETH LChief Executive OfficerSep 06Buy1.025,9006,0011,837,806Sep 07 10:28 AM
LONDONER KENNETH LChief Executive OfficerSep 02Buy1.086,4006,9101,831,204Sep 07 10:28 AM
LONDONER KENNETH LChief Executive OfficerSep 01Buy1.0817,24018,7041,824,804Sep 02 12:51 PM
CHAUSSY STEVEChief Financial OfficerSep 01Buy1.1311,42512,9291,051,553Sep 02 09:35 AM
LONDONER KENNETH LChief Executive OfficerAug 30Buy1.089,0009,7401,807,564Aug 31 10:05 AM
Sieckhaus JohnChief Operating OfficerAug 30Buy1.075,0005,33565,000Sep 01 06:00 AM
LONDONER KENNETH LChief Executive OfficerAug 29Buy1.098,8509,6181,798,564Aug 31 10:05 AM
LONDONER KENNETH LChief Executive OfficerAug 26Buy1.138,2769,3811,789,714Aug 29 09:44 AM
LONDONER KENNETH LChief Executive OfficerAug 25Buy1.198,45010,0331,781,438Aug 29 09:44 AM
Fleming GrayChief Commercial OfficerAug 24Buy1.1836,03642,52236,036Aug 31 01:34 PM
Gallagher Patrick JosephDirectorAug 24Buy1.1617,00019,720100,000Aug 25 02:26 PM
Sieckhaus JohnChief Operating OfficerAug 24Buy1.1310,00011,34760,000Aug 25 06:02 AM
LONDONER KENNETH LChief Executive OfficerAug 23Buy1.0912,00013,0401,772,988Aug 24 11:01 AM
CHAUSSY STEVEChief Financial OfficerAug 22Buy1.138,0009,0161,040,128Aug 24 10:17 AM
LONDONER KENNETH LChief Executive OfficerAug 19Buy1.0010,00010,0301,760,988Aug 22 08:48 AM
LONDONER KENNETH LChief Executive OfficerAug 17Buy0.9713,10012,6591,750,988Aug 19 09:30 AM
LONDONER KENNETH LChief Executive OfficerAug 16Buy0.9025,10022,6021,737,888Aug 17 11:00 AM